English | Español
Patient Daily | Mar 22, 2026

Sana’s cell therapy sustains insulin production through 14 months in a T1D patient
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug
Patient Daily | Mar 22, 2026

Structure Therapeutics reports competitive results for oral weight loss drug in Phase 2 study
Patient Daily | Mar 22, 2026

White House urges Kennedy to shift vaccine stance as election approaches
Patient Daily | Mar 22, 2026

Expert discusses impact of reality TV disclosures on sexual trauma healing
Patient Daily | Mar 22, 2026

Penn researchers receive up to $7.8 million for lymphatic system imaging project
Patient Daily | Mar 22, 2026

Study links sleep-like brain activity to attention lapses in adults with ADHD

Trending
+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+ Regulatory
A. R. Baird | Jun 15, 2026

Health care reform group launches campaign linking consolidation to rising costs
+ Pharmaceuticals
Patient Daily | Jun 16, 2026

Intellia gene editing therapy shows strong results in hereditary angioedema study
+ Pharmaceuticals
Patient Daily | Jun 17, 2026

PwC reports strong biopharma M&A activity as sector shifts to precision science